eTNS for Epilepsy
The Monarch external Trigeminal Nerve Stimulation (eTNS) system is an innovative medical device that offers non-invasive cranial nerve stimulation for treating epilepsy. Until recently, vagus nerve stimulation (VNS), which requires a surgically-implanted device, was the only cranial nerve stimulation available to epilepsy patients.
The Monarch eTNS system offers a new path for epilepsy patients by providing safe and effective cranial nerve stimulation with a device that does not require surgery. To learn how Monarch can help you or a loved one regain control of their life, request more information or for immediate answers.
What is Epilepsy?
Epilepsy is a medical condition characterized by recurrent seizures. It affects up to 1% of the population. Many individuals continue to suffer seizures despite trying multiple medications. Currently, there are few good treatment options available to these patients, who often are often forced to suffer with their disease unabated. Surgery and vagal nerve stimulation are accepted treatments, but these therapies often have significant side effects and usually require hospitalization. The Monarch eTNS system offers new hope as adjunctive therapy for patients with epilepsy.
Treating Epilepsy with eTNS
Physicians at the University of California at Los Angeles (UCLA) invented the eTNS System. Two separate clinical trials showed it to be safe and effective for treating epilepsy. The journal Neurology published findings from these trials in 2009 and 2013. Results from the double-blind trial indicate that 40.5% of patients using the Monarch eTNS System reported their number of seizures decreased by 50% or more after 18 weeks of treatment. Patients receiving eTNS also experienced significant improvements in mood and depressive symptoms, making eTNS unique among epilepsy treatments.
Treatment of epilepsy with eTNS is easy and convenient. Patients use the system in the comfort of their own home. The device is about the size of a cell phone. A wire is attached to a small patch that adheres to a patient's forehead, just above the eyebrows. Patients typically describe stimulation as a tingling sensation and most choose to deliver the therapy at night while they are asleep.
The Monarch eTNS system has received CE Mark approval and is now available in the European Union.
To obtain a Monarch eTNS system, please contact us and a NeuroSigma representative will be in touch soon.